Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy

[1]  Chan Zhang,et al.  MicroRNA-384-5p/Beclin-1 As Potential Indicators For Epigallocatechin Gallate Against Cardiomyocytes Ischemia Reperfusion Injury By Inhibiting Autophagy Via PI3K/Akt Pathway , 2019, Drug design, development and therapy.

[2]  P. Buzzacott,et al.  Biphasic effects of autophagy on decompression bubble‐induced endothelial injury , 2019, Journal of cellular and molecular medicine.

[3]  Peili Bu,et al.  Trimetazidine ameliorates sunitinib-induced cardiotoxicity in mice via the AMPK/mTOR/autophagy pathway , 2019, Pharmaceutical biology.

[4]  Jun Zhuo,et al.  Tranilast Treatment Attenuates Cerebral Ischemia‐Reperfusion Injury in Rats Through the Inhibition of Inflammatory Responses Mediated by NF‐κB and PPARs , 2018, Clinical and translational science.

[5]  A. Ahangarpour,et al.  The Beneficial Effects of Trimetazidine on Reperfusion–Induced Arrhythmia in Diabetic Rats , 2018, Experimental and Clinical Endocrinology & Diabetes.

[6]  Y. Maejima,et al.  The Role of Autophagy in the Heart. , 2018, Annual review of physiology.

[7]  Liliang Shu,et al.  Troxerutin Protects Against Myocardial Ischemia/Reperfusion Injury Via Pi3k/Akt Pathway in Rats , 2017, Cellular Physiology and Biochemistry.

[8]  Y. Li,et al.  Knockdown of MicroRNA-122 Protects H9c2 Cardiomyocytes from Hypoxia-Induced Apoptosis and Promotes Autophagy , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[9]  Ying Tang,et al.  Trimetazidine Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury by Promoting AMP-activated Protein Kinase–dependent Autophagic Flux , 2017, Journal of cardiovascular pharmacology.

[10]  V. Dilsizian,et al.  Myocardial Viability: Survival Mechanisms and Molecular Imaging Targets in Acute and Chronic Ischemia , 2017, Circulation research.

[11]  David M. Sabatini,et al.  mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.

[12]  Liang Hu,et al.  Myocardial Ischemic Postconditioning Promotes Autophagy against Ischemia Reperfusion Injury via the Activation of the nNOS/AMPK/mTOR Pathway , 2017, International journal of molecular sciences.

[13]  Ling Gao,et al.  Berbamine postconditioning protects the heart from ischemia/reperfusion injury through modulation of autophagy , 2017, Cell Death & Disease.

[14]  A. Stephanou,et al.  Antiphospholipid antibodies enhance rat neonatal cardiomyocyte apoptosis in an in vitro hypoxia/reoxygenation injury model via p38 MAPK , 2017, Cell Death & Disease.

[15]  Á. Tósaki,et al.  Autophagy: an adaptive physiological countermeasure to cellular senescence and ischaemia/reperfusion‐associated cardiac arrhythmias , 2016, Journal of cellular and molecular medicine.

[16]  P. LoRusso.  Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Shengjie Wu,et al.  MicroRNA‐21 protects against cardiac hypoxia/reoxygenation injury by inhibiting excessive autophagy in H9c2 cells via the Akt/mTOR pathway , 2016, Journal of cellular and molecular medicine.

[18]  Yan Zhu,et al.  Danshensu alleviates cardiac ischaemia/reperfusion injury by inhibiting autophagy and apoptosis via activation of mTOR signalling , 2016, Journal of cellular and molecular medicine.

[19]  Ying Wang,et al.  Geniposide Prevents Hypoxia/Reoxygenation-Induced Apoptosis in H9c2 Cells: Improvement of Mitochondrial Dysfunction and Activation of GLP-1R and the PI3K/AKT Signaling Pathway , 2016, Cellular Physiology and Biochemistry.

[20]  Yun Zhang,et al.  Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy , 2016, Journal of Translational Medicine.

[21]  P. Zhu,et al.  The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway. , 2016, Metabolism: clinical and experimental.

[22]  D. Yellon,et al.  Targeting Myocardial Reperfusion Injury--The Search Continues. , 2015, The New England journal of medicine.

[23]  L. Blatter,et al.  Distinct mPTP activation mechanisms in ischaemia-reperfusion: contributions of Ca2+, ROS, pH, and inorganic polyphosphate. , 2015, Cardiovascular research.

[24]  E. Gao,et al.  Vitamin D receptor activation protects against myocardial reperfusion injury through inhibition of apoptosis and modulation of autophagy. , 2015, Antioxidants & redox signaling.

[25]  J. Roselló-Catafau,et al.  Sirtuin 1 in rat orthotopic liver transplantation: an IGL-1 preservation solution approach. , 2015, World journal of gastroenterology.

[26]  Á. Tósaki,et al.  The cellular autophagy markers Beclin-1 and LC3B-II are increased during reperfusion in fibrillated mouse hearts. , 2013, Current pharmaceutical design.

[27]  L. Berghella,et al.  The metabolic modulator trimetazidine triggers autophagy and counteracts stress‐induced atrophy in skeletal muscle myotubes , 2013, The FEBS journal.

[28]  J. Roselló-Catafau,et al.  AMPK involvement in endoplasmic reticulum stress and autophagy modulation after fatty liver graft preservation: a role for melatonin and trimetazidine cocktail , 2013, Journal of pineal research.

[29]  L. Blatter,et al.  Mitochondria-mediated cardioprotection by trimetazidine in rabbit heart failure. , 2013, Journal of molecular and cellular cardiology.

[30]  Q. Wang,et al.  Mechanisms underlying protective effects of trimetazidine on endothelial progenitor cells biological functions against H2O2-induced injury: involvement of antioxidation and Akt/eNOS signaling pathways. , 2013, European journal of pharmacology.

[31]  F. Vaillant,et al.  Trimetazidine demonstrated cardioprotective effects through mitochondrial pathway in a model of acute coronary ischemia , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

[32]  C. Weinheimer,et al.  Autophagy is impaired in cardiac ischemia-reperfusion injury , 2012, Autophagy.

[33]  Xiaoping Zhou,et al.  Trimetazidine Protects against Smoking-Induced Left Ventricular Remodeling via Attenuating Oxidative Stress, Apoptosis, and Inflammation , 2012, PloS one.

[34]  J. Ge,et al.  Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis. , 2012, Journal of the American College of Cardiology.

[35]  A. Maity,et al.  PI3K/AKT/mTOR Pathway in Angiogenesis , 2011, Front. Mol. Neurosci..

[36]  Jiang-wei Ma,et al.  Evaluation of the Antioxidant Potential of Salvia miltiorrhiza Ethanol Extract in a Rat Model of Ischemia-Reperfusion Injury , 2011, Molecules.

[37]  N. Hariharan,et al.  Is Autophagy in Response to Ischemia and Reperfusion Protective or Detrimental for the Heart? , 2011, Pediatric Cardiology.

[38]  Youngil Lee,et al.  Bnip3-mediated mitochondrial autophagy is independent of the mitochondrial permeability transition pore , 2010, Autophagy.

[39]  K. Hideg,et al.  Trimetazidine, Administered at the Onset of Reperfusion, Ameliorates Myocardial Dysfunction and Injury by Activation of p38 Mitogen-Activated Protein Kinase and Akt Signaling , 2010, Journal of Pharmacology and Experimental Therapeutics.

[40]  Chang Hwa Jung,et al.  mTOR regulation of autophagy , 2010, FEBS letters.

[41]  R. Gottlieb,et al.  Autophagy in Ischemic Heart Disease , 2009, Circulation research.

[42]  G. Kroemer,et al.  Autophagic cell death: the story of a misnomer , 2008, Nature Reviews Molecular Cell Biology.

[43]  Janet L. Johnstone,et al.  Intracellular Protein Aggregation Is a Proximal Trigger of Cardiomyocyte Autophagy , 2008, Circulation.

[44]  J. Sadoshima.  The role of autophagy during ischemia/reperfusion , 2008, Autophagy.

[45]  A. Barsotti,et al.  Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy. , 2007, American heart journal.

[46]  J. Richardson,et al.  Cardiac autophagy is a maladaptive response to hemodynamic stress. , 2007, The Journal of clinical investigation.

[47]  T. Asano,et al.  Distinct Roles of Autophagy in the Heart During Ischemia and Reperfusion: Roles of AMP-Activated Protein Kinase and Beclin 1 in Mediating Autophagy , 2007, Circulation research.

[48]  Y. Rui-xing,et al.  Trimetazidine inhibits cardiomyocyte apoptosis in a rabbit model of ischemia-reperfusion. , 2007, Translational research : the journal of laboratory and clinical medicine.

[49]  L. Argaud,et al.  Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury. , 2005, Journal of molecular and cellular cardiology.

[50]  D. Cokkinos,et al.  Trimetazidine protects isolated rat hearts against ischemia–reperfusion injury in an experimental timing – dependent manner , 2005, Basic Research in Cardiology.

[51]  A. Barsotti,et al.  Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy , 2005, Heart.

[52]  T. P. Neufeld,et al.  Guidelines for the use and interpretation of assays for monitoring autophage , 2012 .